Indergiri Finance reported a net loss of Rs 1.38 crore for FY26. Auditors have raised significant concerns over the company's ability to continue as a going concern, citing a failure to meet RBI-mandated Net Owned Fund requirements and a stalled capital-raising plan.
Indergiri Finance FY26 Results and Regulatory Audit
Net Loss: Rs 1.38 crore | Net Owned Fund: Negative Rs 0.64 crore
Reader Takeaway: Persistent capital deficiency and auditor-flagged insolvency risks create high uncertainty for shareholders regarding company viability.
What just happened
Indergiri Finance has released its Annual Report for FY 2025-26, disclosing a net loss of Rs 1.38 crore. While this marks a marginal improvement from the previous year's loss of Rs 1.57 crore, the company's regulatory standing has deteriorated significantly. The firm has failed to meet the RBI’s mandatory Net Owned Fund (NOF) requirement of Rs 5 crore, reporting a negative NOF of Rs 0.64 crore as of March 31, 2026.
Why this matters
The company is now in formal contravention of the RBI’s Scale Based Regulation (SBR) framework. Auditors M/s. Sampat & Mehta LLP have issued a qualified opinion, citing a 'Material Uncertainty Related to Going Concern.' This signals that the company’s ability to remain operational is under serious scrutiny, especially given that a proposed Rs 10 crore rights issue intended to restore capital compliance has not been completed.
Management Commentary
The board confirmed receiving a show-cause notice from the RBI in January 2026 regarding the NOF shortfall. Despite the missed timeline for its fundraising efforts, management claims they remain confident in rectifying the capital deficiency and have prepared the financial statements under the going concern assumption. Additionally, the company has proposed a revision to the Managing Director and CFO’s remuneration, moving it to a range of Rs 45-60 lakhs, which awaits shareholder approval at the AGM on September 30, 2026.
Risks to watch
The primary risk remains the potential cancellation of the company's Certificate of Registration (CoR) by the RBI. Investors should prioritize monitoring any updates on capital infusion, as the current liquidity and capital position are insufficient to meet regulatory standards.
What to track next
Watch for developments regarding the delayed rights issue and any subsequent communication from the RBI following the show-cause notice.